Actively Recruiting

Phase Not Applicable
Age: 20Years - 80Years
All Genders
NCT06116942

Magnetic Brain Stimulation and Computer-based Motor Training for Rehabilitation After Stroke

Led by Max Planck Institute for Human Cognitive and Brain Sciences · Updated on 2023-11-09

24

Participants Needed

1

Research Sites

201 weeks

Total Duration

On this page

Sponsors

M

Max Planck Institute for Human Cognitive and Brain Sciences

Lead Sponsor

U

University of Halle Medical Faculty

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of the present clinical trial is to explore whether an innovative technology-based approach can help individuals who have had a stroke and can no longer move their hands with ease. Our approach consists of a combination of two technologies: Transcranial Magnetic Stimulation (TMS) and a Brain-Computer Interface (BCI). The former entails the application of magnetic fields over the head to stimulate the brain preparing it for a better ability to produce movement. The latter consists of measuring brain activity to personalize a type of computer-based training that is designed to increase communication between the brain and the muscles.

CONDITIONS

Official Title

Magnetic Brain Stimulation and Computer-based Motor Training for Rehabilitation After Stroke

Who Can Participate

Age: 20Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of a subcortical stroke at least 6 months before the trial confirmed by MRI or CT
  • Moderate to severe hemiparesis in an upper limb
  • Sufficient language comprehension and visual and auditory perception to engage in Brain Computer Interface training
  • Age between 20 and 80 years old
  • Clear consciousness and stable vital signs
  • Eligible for MRI, EEG, BCI, and TMS procedures
Not Eligible

You will not qualify if you...

  • Current or recent drug abuse or medication changes affecting the central nervous system (e.g., benzodiazepines, serotoninergic and dopaminergic agents)
  • History of seizures
  • Bone, joint, or muscle diseases
  • Peripheral neuropathy or other neurological or psychiatric conditions (including tinnitus, migraine, mood disorders except mild to moderate depression with Beck depression scale score below 29)
  • Severe cognitive deficits with Montreal Cognitive Assessment score 24 or below
  • Lesions in the upper extremities
  • Severe spasticity (greater than 3) or pain affecting wrist extension
  • Contraindications for TMS (history of seizures, epilepsy, unclear unconsciousness, migraines, metals in the head)
  • Contraindications for MRI (metals in the body, metallic prosthetics, claustrophobia)
  • Participation in BCI or rTMS interventional trials within the last 6 months
  • Participation in any other interventional clinical trial
  • Suspected inability to comply with study procedures
  • Pregnancy or nursing

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Max Planck Institute for Human Cognitive and Brain Sciences

Leipzig, Saxony, Germany, 04103

Actively Recruiting

Loading map...

Research Team

A

Aimee Arely Flores Sandoval, MsC

CONTACT

A

Arno Villringer, MD PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here